Pneumonia

Discovery of key protein's shape could lead to improved bacterial pneumonia vaccine

Scientists at St. Jude Children's ResearchHospital have discovered that the shape of a protein on the surface ofpneumonia bacteria helps these germs invade the human bloodstream. Thisfinding, published Dec. 16 online by the EMBO Journal, could helpscientists develop a vaccine that is significantly more effective atprotecting children against the disease. The St. Jude researchersdetermined t...

Measuring hormone cuts antibiotic use in half in pneumonia patients

Measuring a hormone in the blood can help doctors greatly reduce the number of days pneumonia patients have to take antibiotics to cure their infection, according to a study to be presented at the American Thoracic Society International Conference on May 24. In the study, pneumonia patients whose level of the hormone procalcitonin was measured during the course of their illness took antibi...

Bocavirus infection may be associated with pneumonia in Thailand, especially in children

The newly identified human bocavirus was found in nearly 5 percent of pneumonia patients in rural Thailand, mostly in very young children. Researchers from the Centers for Disease Control and Prevention report their findings today at the International Conference on Emerging Infectious Diseases "Our preliminary data suggests that human bocavirus may be associated with pneumonia in Thailand...

Cell wall of pneumonia bacteria can cause brain and heart damage

Investigators at St. Jude Children's Research Hospital have discovered in mouse models how cell walls from certain pneumonia-causing bacteria can cause fatal heart damage; researchers have also shown how antibiotic therapy can contribute to this damage by increasing the number of cell wall pieces shed by dying bacteria. The team also demonstrated in a mouse model how to prevent this from happenin...

UGA scientists unravel 'molecular inch-worm' structure of walking-pneumonia bacterium

Researchers at the University of Georgia, using glow-in-the-dark proteins and microcinematography, have helped unravel the development and function of a complex organelle in the bacterium that causes "walking pneumonia." The researchers have described in new, precise detail the unique cell extension that forms on one end of the bacterium Mycoplasma pneumoniae. This structure, called a "ter...

More>>

Pneumonia at Biology Products

Chlamydia pneumonia IgM ELISA Kit, Single from Bio-Quant Inc.

Description:Request Info...
Company:Bio-Quant Inc.

Chlamydia pneumonia IgA ELISA Kit, Single from Bio-Quant Inc.

Description:Request Info...
Company:Bio-Quant Inc.

Anti-Chlamydia pneumoniae (TWAR) Monoclonal Antibody, Unconjugated from ViroStat Inc.

Description:Chlamydia pneumoniae (TWAR)...
Company:ViroStat Inc.

Pneumonia at Biology Technology

Actinobacillus pleuropneumoniae

Actinobacillus pleuropneumo...

Actinobacillus pleuropneumoniae

Actinobacillus pleuropneumo...

Pneumonia at Medicine News

Toxin connected to 'Flesh-eating' Pneumonia in Kids

According to French Researchers, Staphylococcal bacteria carrying a specific toxin can cause a severe, highly lethal type of pneumonia in otherwise healthy children and young adults.// They have so far linked infection with these toxin-carrying bugs to 30 cases of pneumonia marked by widespread tissue destruction in the respiratory tract. According to new study's authors led by Dr. Je...

A new Vaccine for Pneumonia

Researchers show a new type of vaccine can reduce the incidence of pneumonia in children with and without human immunodeficiency virus (HIV). // Acute respiratory infections are a major cause of death in children under age 5. Additionally, pneumonia is becoming increasingly resistant to antibiotics. Doctors from around the world are in search of new methods to treat the illness.Resear...

The After Effects Of Pneumonia

A new study shows surviving pneumonia may mean just a short-term lease on a healthy life, but it depends on the patient. Results of the study show // increasing age combined with cardiovascular disease, cerebrovascular disease, an altered mental state, and anemia were significant and independent predictors of death in the two to three years after being hospitalized for pneumonia. In addi...

Acid Suppressive Drugs Found To Increase The Risk for Pneumonia

A recent study shows that people who use stomach-acid suppressive medications for indigestion or gastroesophageal reflux disease (GERD) may be at an increased risk of developing pneumonia .// The use of acid-suppressive drugs for the stomach can increase vulnerability to infections, as stomach acidity is a major defense mechanism for ingested pathogens. Researchers studied pneumonia ra...

Tsunami Survivors Face Pneumonia Threat

Initially it was feared that diseases such as cholera would take the heaviest toll on survivors of the Indian Ocean tsunami. But overcrowding at refugee camps has intensified// the spread of pneumonia, and health officials fear that respiratory diseases may claim many lives in the already devastated region. In the days following the tsunami on 26 December last year, groups such as the...

More>>

Pneumonia at Medicine Products

NOW® Streptococcus pneumoniae Test

Description:What if it is not the Flu? Streptococcus pneumoniae is a leading cause of acute bacterial "flu-like" infections. The easy-to-use, rapid, urine-based test allows for identification and treatment selection within the new 4 hour guidelines. Rapid identification can lead to better treatment decisions, improved patient outcomes and lower overall health care costs. Intended use: The NOW® St...
Company:Binax, Inc.

ImmunoWELL Mycoplasma pneumoniae Antibody (IgG) Test

Description:The ImmunoWELL Mycoplasma Pneumoniae Antibody (IgG) Test is a semiquantitative enzyme immunoassay (EIA) for the detection of clinically significant IgG antibodies to M. pneumoniae between acute and convalescent human serum specimens. The test should not be used for specimens found reactive with ImmunoWELL Mycoplasma Pneumoniae Antibody (IgM) Test and is not intended for qualitative (one specimen)...
Company:GenBio

ImmunoWELL Mycoplasma pneumoniae Antibody (IgM) Test

Description:The ImmunoWELL Mycoplasma Pneumoniae Antibody (IgM) Test is a qualitative enzyme immunoassay (EIA) for the detection of specific IgM antibodies to M. pneumoniae in serum and is an aid in the diagnosis of M. pneumoniae infection....
Company:GenBio

MGB Alert Chlamydia pneumoniae ASR*

Description:MGB Alert Detection Reagents provide molecular labs a more advanced alternative for real-time PCR based assays. By using our MGB technology, combined with post-PCR dissociation melt curve analysis, Nanogen is now able to provide molecular labs more powerful tools for detecting nucleic acid sequences of specific organisms or genetic mutations associated with disease, as well as enabling labs to pr...
Company:Nanogen, Inc.

MGB Alert Mycoplasma pneumoniae ASR*

Description:MGB Alert Detection Reagents provide molecular labs a more advanced alternative for real-time PCR based assays. By using our MGB technology, combined with post-PCR dissociation melt curve analysis, Nanogen is now able to provide molecular labs more powerful tools for detecting nucleic acid sequences of specific organisms or genetic mutations associated with disease, as well as enabling labs to pr...
Company:Nanogen, Inc.

More>>

Pneumonia at Medicine Technology

Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial

Provides Update to Timeline for Second Pivotal Phase 3 Trial CL-05 CHICAGO, July 02, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced the confirmation ofsupplemental efficacy data from Trial CL-06, the first of twopivotal Phase 3 clinical trials designed to assess the safety andeffectiveness of cethromycin, a novel once-a-day antibiotic, forthe treatme...

Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycin's First of Two Phase 3 Pneumonia Trials

CHICAGO, June 29, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced that it will host aconference call and live webcast at 10:00 am (EDT) on Monday, July2, 2007 to discuss data from Trial CL-06, the first of two pivotalPhase 3 clinical trials designed to assess the safety andeffectiveness of cethromycin, a novel once-a-day antibiotic, forthe treatment...

Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial

CHICAGO, June 21, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced positive results fromTrial CL-06, the first of two pivotal Phase 3 clinical trialsdesigned to assess the safety and effectiveness of cethromycin, anovel once-a-day antibiotic, for the treatment of communityacquired pneumonia (CAP). In the study, cethromycin achievednon-inferiority in i...

July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia

WALTHAM, Mass.--(BUSINESS WIRE)--Jun 12, 2007 - Results from thesuccessful clinical trial of Oscient Pharmaceuticals' (Nasdaq:OSCI) FACTIVE(R) (gemifloxacin mesylate) tablets for the five-daytreatment of community-acquired pneumonia of mild to moderateseverity (CAP) have been published in the July issue of thepeer-reviewed Journal of Antimicrobial Chemotherapy, currentlyavailable in advance...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

SAN FRANCISCO--(BUSINESS WIRE)--May 21, 2007 - Medicalprofessionals seeking to treat the serious and growing problem ofhospital-acquired gram-negative pneumonia may have a new weapon:NKTR-061 (inhaled-amikacin), which is a product candidate beingdeveloped by Nektar Therapeutics (Nasdaq:NKTR). Results of a Phase 2a clinical trial evaluating the use ofNKTR-061 (Inhaled Amikacin) to treat me...

Pneumonia at Medicine Dictionary

Viral pneumonia

. It can be in just one part of the <a href="/ ?q=/ Medicine-Dictionar...

Pneumonia

, amoebae...

Mycoplasma pneumonia

...

Lobar pneumonia

) - affects <a href="/ ?q=/ Medicine-...

Bronchopneumonia

More on that can be caused by a bacterium, usually Streptococcus <a href="/ ?q=/ Medicine-...

More>>